176 related articles for article (PubMed ID: 12925557)
1. The ACE gene I/D polymorphism is not associated with the blood pressure and cardiovascular benefits of ACE inhibition.
Harrap SB; Tzourio C; Cambien F; Poirier O; Raoux S; Chalmers J; Chapman N; Colman S; Leguennec S; MacMahon S; Neal B; Ohkubo T; Woodward M;
Hypertension; 2003 Sep; 42(3):297-303. PubMed ID: 12925557
[TBL] [Abstract][Full Text] [Related]
2. A study of the relationships between angiotensin- converting enzyme gene, chymase gene polymorphisms, pharmacological treatment with ACE inhibitor and regression of left ventricular hypertrophy in essential hypertension patients treated with benazepril.
He H; Li LM; Cao WH; Sun NL; Liu MZ; Hu YH
Ann Hum Biol; 2005; 32(1):30-43. PubMed ID: 15788353
[TBL] [Abstract][Full Text] [Related]
3. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack.
PROGRESS Collaborative Group
Lancet; 2001 Sep; 358(9287):1033-41. PubMed ID: 11589932
[TBL] [Abstract][Full Text] [Related]
4. Reduction of pneumonia risk by an angiotensin I-converting enzyme inhibitor in elderly Japanese inpatients according to insertion/deletion polymorphism of the angiotensin I-converting enzyme gene.
Takahashi T; Morimoto S; Okaishi K; Kanda T; Nakahashi T; Okuro M; Murai H; Nishimura Y; Iwai K; Matsumoto M
Am J Hypertens; 2005 Oct; 18(10):1353-9. PubMed ID: 16202861
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin-converting enzyme gene polymorphism predicts the time-course of blood pressure response to angiotensin converting enzyme inhibition in the AASK trial.
Bhatnagar V; O'Connor DT; Schork NJ; Salem RM; Nievergelt CM; Rana BK; Smith DW; Bakris GL; Middleton JP; Norris KC; Wright JT; Cheek D; Hiremath L; Contreras G; Appel LJ; Lipkowitz MS
J Hypertens; 2007 Oct; 25(10):2082-92. PubMed ID: 17885551
[TBL] [Abstract][Full Text] [Related]
6. [The hemostasis parameters and ACE gene polymorphism in patients with essential hypertension treated with perindopril].
Janczak-Bazan A
Ann Acad Med Stetin; 2006; 52(1):51-61; discussion 61-2. PubMed ID: 17131847
[TBL] [Abstract][Full Text] [Related]
7. [ADVANCE study: objectives, design and current status].
Chalmers J
Drugs; 2003; 63 Spec No 1():39-44. PubMed ID: 12708881
[TBL] [Abstract][Full Text] [Related]
8. Impact of angiotensin-converting enzyme gene polymorphism on proteinuria and arterial hypertension.
Zivko M; Kusec R; Galesić K
Coll Antropol; 2013 Sep; 37(3):765-70. PubMed ID: 24308214
[TBL] [Abstract][Full Text] [Related]
9. PROGRESS - Perindopril Protection Against Recurrent Stroke Study: characteristics of the study population at baseline. Progress Management Committee.
J Hypertens; 1999 Nov; 17(11):1647-55. PubMed ID: 10608480
[TBL] [Abstract][Full Text] [Related]
10. Drug-gene interaction between the insertion/deletion polymorphism of the angiotensin-converting enzyme gene and antihypertensive therapy.
Schelleman H; Klungel OH; van Duijn CM; Witteman JC; Hofman A; de Boer A; Stricker BH
Ann Pharmacother; 2006 Feb; 40(2):212-8. PubMed ID: 16449550
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenetic association of the angiotensin-converting enzyme insertion/deletion polymorphism on blood pressure and cardiovascular risk in relation to antihypertensive treatment: the Genetics of Hypertension-Associated Treatment (GenHAT) study.
Arnett DK; Davis BR; Ford CE; Boerwinkle E; Leiendecker-Foster C; Miller MB; Black H; Eckfeldt JH
Circulation; 2005 Jun; 111(25):3374-83. PubMed ID: 15967849
[TBL] [Abstract][Full Text] [Related]
12. Does angiotensin-converting enzyme gene polymorphism affect blood pressure? Findings after 6 years of follow-up in healthy subjects.
Di Pasquale P; Cannizzaro S; Paterna S
Eur J Heart Fail; 2004 Jan; 6(1):11-6. PubMed ID: 15012913
[TBL] [Abstract][Full Text] [Related]
13. Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease.
Tzourio C; Anderson C; Chapman N; Woodward M; Neal B; MacMahon S; Chalmers J;
Arch Intern Med; 2003 May; 163(9):1069-75. PubMed ID: 12742805
[TBL] [Abstract][Full Text] [Related]
14. Perindopril-based blood pressure-lowering reduces major vascular events in patients with atrial fibrillation and prior stroke or transient ischemic attack.
Arima H; Hart RG; Colman S; Chalmers J; Anderson C; Rodgers A; Woodward M; MacMahon S; Neal B;
Stroke; 2005 Oct; 36(10):2164-9. PubMed ID: 16141420
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin-converting enzyme inhibition by perindopril in the treatment of cardiovascular disease.
Brugts JJ; Ferrari R; Simoons ML
Expert Rev Cardiovasc Ther; 2009 Apr; 7(4):345-60. PubMed ID: 19379059
[TBL] [Abstract][Full Text] [Related]
16. Effects of perindopril treatment on hemostatic function in patients with essential hypertension in relation to angiotensin converting enzyme (ACE) and plasminogen activator inhibitor-1 (PAI-1) gene polymorphisms.
Jastrzebskal M; Widecka K; Naruszewicz M; Ciechanowicz A; Janczak-Bazan A; Foltynska A; Goracy I; Chetstowski K; Wesotowska T
Nutr Metab Cardiovasc Dis; 2004 Oct; 14(5):259-69. PubMed ID: 15673060
[TBL] [Abstract][Full Text] [Related]
17. Endothelial cell damage and angiotensin-converting enzyme insertion/deletion genotype in elderly hypertensive patients.
Kario K; Matsuo T; Kobayashi H; Kanai N; Hoshide S; Mitsuhashi T; Ikeda U; Nishiuma S; Matsuo M; Shimada K
J Am Coll Cardiol; 1998 Aug; 32(2):444-50. PubMed ID: 9708474
[TBL] [Abstract][Full Text] [Related]
18. Effects of an angiotensin-converting enzyme inhibitor-based regimen on pneumonia risk.
Ohkubo T; Chapman N; Neal B; Woodward M; Omae T; Chalmers J;
Am J Respir Crit Care Med; 2004 May; 169(9):1041-5. PubMed ID: 14990394
[TBL] [Abstract][Full Text] [Related]
19. [Association between angiotensin converting enzyme gene, chymase gene and regression of left ventricular hypertrophy in patients treated with angiotensin converting enzyme inhibitors].
He H; Li LM; Cao WH; Liu MZ; Sun NL; Lü J; Hu YH
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Sep; 25(9):756-60. PubMed ID: 15555355
[TBL] [Abstract][Full Text] [Related]
20. Effect of ACE insertion/deletion and 12 other polymorphisms on clinical outcomes and response to treatment in the LIFE study.
Nordestgaard BG; Kontula K; Benn M; Dahlöf B; de Faire U; Edelman JM; Eliasson E; Fyhrquist F; Hille DA; Ibsen H; Lyle PA; Berg K; Sandberg M; Sethi AA; Wong PH; Os I
Pharmacogenet Genomics; 2010 Feb; 20(2):77-85. PubMed ID: 20065889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
